Zoetis (ZTS) Net Income towards Common Stockholders (2012 - 2026)
Zoetis (ZTS) posted Net Income towards Common Stockholders of $866 million for Q2 2026, down 5.0% from $912 million a year earlier but up 14.2% from the prior quarter.
Powered by 
Analysis
Zoetis (ZTS) Net Income towards Common Stockholders (2012 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Net Income towards Common Stockholders at Zoetis was $3.27 billion, down 0.6% year-over-year; for FY2025, it came in at $3.36 billion, up 7.2% from FY2024.
- Annual Net Income towards Common Stockholders has increased for ten consecutive years, with a five-year compound annual growth rate of 11.0% (FY2020 to FY2025).
- In prior years, Zoetis' Net Income towards Common Stockholders was $3.13 billion in FY2024 (+6.7%), $2.94 billion in FY2023 (+10.5%), $2.66 billion in FY2022 (+6.8%) and $2.49 billion in FY2021 (+24.6%).
- Quarterly Net Income towards Common Stockholders has run from a low of $506 million in Q4 2021 to a high of $912 million in Q2 2025 over five years.
- On a year-over-year basis, Net Income towards Common Stockholders increased in six of the last eight quarters, with growth averaging 6.7%.
- The strongest year-over-year quarter for Net Income towards Common Stockholders in the past five years was Q2 2023, with growth of 30.1%; the weakest was Q2 2024, with a decline of 10.6%.
- According to Business Quant data, Net Income towards Common Stockholders for the three prior quarters was $758 million (Q1 2026), $761 million (Q4 2025) and $887 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,146.94 Bn | 1,115.53 Bn | 19.71 Bn | 7.10 Bn |
| 2 | Johnson & Johnson | 624.96 Bn | 543.49 Bn | 17.26 Bn | 5.53 Bn |
| 3 | AbbVie | 510.15 Bn | 483.27 Bn | 12.70 Bn | 3.61 Bn |
| 4 | Merck | 366.13 Bn | 320.51 Bn | 12.21 Bn | -1.34 Bn |
| 5 | Novartis Ag | 297.75 Bn | 261.74 Bn | 11.24 Bn | 3.26 Bn |
| 6 | Astrazeneca | 261.93 Bn | 235.62 Bn | 12.86 Bn | 2.51 Bn |
| 7 | Amgen | 236.51 Bn | 191.91 Bn | 7.24 Bn | 2.38 Bn |
| 8 | Gilead Sciences | 194.27 Bn | 168.47 Bn | 6.22 Bn | -10.50 Bn |
| 9 | Pfizer | 171.74 Bn | 118.39 Bn | 10.94 Bn | -248.00 Mn |
| 10 | Zoetis | 33.38 Bn | 25.23 Bn | 1.80 Bn | 691.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 691.00 Mn |
| Mar 31, 2026 | 601.00 Mn |
| Dec 31, 2025 | 603.00 Mn |
| Sep 30, 2025 | 721.00 Mn |
| Jun 30, 2025 | 726.00 Mn |
| Mar 31, 2025 | 602.00 Mn |
| Dec 31, 2024 | 581.00 Mn |
| Sep 30, 2024 | 682.00 Mn |
| Jun 30, 2024 | 624.00 Mn |
| Mar 31, 2024 | 599.00 Mn |
| Dec 31, 2023 | 525.00 Mn |
| Sep 30, 2023 | 596.00 Mn |
| Jun 30, 2023 | 671.00 Mn |
| Mar 31, 2023 | 552.00 Mn |
| Dec 31, 2022 | 461.00 Mn |
| Sep 30, 2022 | 529.00 Mn |
| Jun 30, 2022 | 529.00 Mn |
| Mar 31, 2022 | 595.00 Mn |
| Dec 31, 2021 | 414.00 Mn |
| Sep 30, 2021 | 552.00 Mn |
API Access
Zoetis Net Income towards Common Stockholders API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=ZTS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-income-towards-common-stockholders", "ticker": "ZTS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=ZTS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();